• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


ADM Tronics Unlimited Expands Medical Device Manufacturing In Northvale, New Jersey

ADM Tronics Unlimited, Inc., a company that specializes in electronic medical device design, development and manufacturing for diagnostic and therapeutic medical technologies, launched a major expansion of its medical device design, engineering and production facilities at its FDA-Registered Medical Device Manufacturing Facility in Northvale, New Jersey.

According to company officials, the acquisition and installation of state-of-the-art capital equipment promises to speed the development of medical device prototypes and enable automated precision manufacturing of components to increase dramatically, which in turn, converts into the opportunity for significant growth in revenues.

"We are excited about bringing this automated production machinery into our engineering infrastructure," stated Andre' DiMino, CEO of ADMT. "And, we are proud to be contributing to the renewed goal of bringing quality manufacturing back to America, especially doing this with equipment also made in America. We believe this investment has the potential to bring us a dramatic return on investment that will only grow over time.”

The addition of the automated CNC machine tool equipment further distinguishes ADMT from its competition, Timothy Gilmartin, Vice President, Production. He said, "In my over three decades with ADMT this is the most dramatic expansion of equipment and capacity we have installed. This is now propelling ADMT to the status of being the company of choice for engineering and developing the most advanced electronic medical device technologies."

"We now have equipment that can give us an end-to-end pipeline for bringing our customers' products, as well as our own proprietary products, from the conceptual stage right into automated manufacturing, all in-house,” Mr. Gilmartin continued.

Exclusive Research